Related Experiment Video
Updated: Jul 14, 2026
10:26
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Unexpected steps in plasma-cell differentiation
Ulf Klein1, Riccardo Dalla-Favera
1Institute for Cancer Genetics & Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St. Nicholas Avenue, New York, NY 10032, USA.
Immunity
|May 25, 2007
Summary
Blimp-1 is a key regulator of plasma cell differentiation. New research reveals an early differentiation stage that does not require Blimp-1, preceding Blimp-1-dependent terminal differentiation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Differentiation
Background:
- The transcriptional repressor Blimp-1 is widely recognized as the master regulator of plasma cell differentiation.
- Understanding the precise molecular events governing plasma cell development is crucial for immunology.
Discussion:
- Kallies et al. (2007) challenge the universal role of Blimp-1 in initiating plasma cell differentiation.
- The study delineates distinct phases in plasma cell development, highlighting a novel Blimp-1-independent stage.
Key Insights:
- Identification of a Blimp-1-independent stage preceding terminal differentiation.
- This finding suggests a more complex regulatory network than previously understood for plasma cell development.
- Blimp-1 acts as a critical regulator specifically during the later stages of terminal differentiation.
Outlook:
- Further research is needed to elucidate the factors driving the Blimp-1-independent differentiation stage.
- This discovery may open new avenues for therapeutic interventions targeting B cell malignancies or autoimmune diseases.
- Investigating the interplay between Blimp-1 and other regulatory factors will refine our model of plasma cell biology.
Related Concept Videos
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...